4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-19-012840
Options or other derivatives
- Chief Commercial Officer acquired 7,337 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Rizvi Qasim · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-12-12 | Grant or award : show line 1 in the form Restricted Share Units | +7,337 | 7,337 | D |
Loading xslF345X03/edgar.xml…